ウミフェノビル
参考資料

1 2  “阿比朵尔抑制新冠，先声药业生产的吗？” (中国語). 全民健康网. 17 June 2020時点のオリジナルよりアーカイブ。17 June 2020閲覧。
↑  “ИНСТРУКЦИЯ ПО ПРИМЕНЕНИЮ АРПЕТОЛ (ARPETOL)” (ベラルーシ語). Vidal. 26 January 2018時点のオリジナルよりアーカイブ。17 June 2020閲覧。
↑  “Full Prescribing Information: Arbidol (umifenovir) film-coated tablets 50 and 100 mg: Corrections and Additions” (ロシア語). State Register of Medicines.   Open joint-stock company “Pharmstandard-Tomskchempharm”. 3 June 2015閲覧。[リンク切れ]
↑  “KEGG DRUG: ウミフェノビル”. www.kegg.jp. 2021年6月15日閲覧。
↑  “International Nonproprietary Names for Pharmaceutical Substances (INN)”. WHO Drug Information 2011; 25(1): 91. 2012年8月18日時点のオリジナルよりアーカイブ。2021年6月15日閲覧。
1 2  “Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol”. Antiviral Research 81 (2):  132–40. (February 2009). doi:10.1016/j.antiviral.2008.10.009. PMID 19028526.
↑  “Разработка Арбидола”.   Фармацевтическая компания «Фармстандарт». 2012年2月3日時点のオリジナルよりアーカイブ。2012年8月13日閲覧。
↑  “АРПЕТОЛ”.   фирма «Лекфарм». 2013年7月16日時点のオリジナルよりアーカイブ。2011年5月11日閲覧。
↑  “FDA Approved Drugs for Influenza”. U.S. Food and Drug Administration (23 October 2020). 2021年6月15日閲覧。
↑  Kadam, Rameshwar U.; Wilson, Ian A. (2017). “Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol”. Proceedings of the National Academy of Sciences 114 (2):  206–214. doi:10.1073/pnas.1617020114. PMC 5240704. PMID 28003465. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240704/.
1 2  “[Sensitivity of various influenza virus strains to arbidol. Influence of arbidol combination with different antiviral drugs on reproduction of influenza virus A”]. Terapevticheskii Arkhiv (ИЗДАТЕЛЬСТВО "МЕДИЦИНА") 77 (8):  84–8. (2005). PMID 16206613. http://arbidol.org/arbidol-2005-works-as-well.html.
↑  “[Efficacy and safety of arbidol in treatment of naturally acquired influenza]”. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 26 (3):  289–93. (June 2004). PMID 15266832.
↑  “Arbidol: a broad-spectrum antiviral compound that blocks viral fusion”. Current Medicinal Chemistry 15 (10):  997–1005. (2008). doi:10.2174/092986708784049658. PMID 18393857.
↑  “Virus susceptibility and clinical effectiveness of anti-influenza drugs during the 2010-2011 influenza season in Russia”. International Journal of Infectious Diseases 43:  77–84. (February 2016). doi:10.1016/j.ijid.2016.01.001. PMID 26775570.
↑  “Russian Pharmaceutical Market 2010”.   DSM Group. 20 December 2018時点のオリジナルよりアーカイブ。17 June 2020閲覧。
↑  “Most popular antiviral medication brands in the Russian pharmaceutical market in 1st quarter 2020 by sales value share”. Statista. 17 June 2020閲覧。
↑  “Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection”. Virology Journal 3:  56. (July 2006). doi:10.1186/1743-422X-3-56. PMC 1559594. PMID 16854226. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1559594/.
↑  “Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo”. Archives of Virology 152 (8):  1447–55. (2007). doi:10.1007/s00705-007-0974-5. PMID 17497238.
↑  “[Mechanisms of arbidole's immunomodulating action]” (ロシア語). Vestnik Rossiiskoi Akademii Meditsinskikh Nauk (3):  36–40. (1999). PMID 10222830.
↑  “Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol”. Biochemistry 46 (20):  6050–9. (May 2007). doi:10.1021/bi700181j. PMC 2532706. PMID 17455911. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2532706/.
↑  “The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses”. Journal of Virology 90 (6):  3086–92. (January 2016). doi:10.1128/JVI.02077-15. PMC 4810626. PMID 26739045. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810626/.
↑  “Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses”. Journal of Virology 93 (8). (April 2019). doi:10.1128/JVI.02185-18. PMC 6450122. PMID 30700611. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450122/.
↑  “Coronavirus: are cocktail therapies for flu and HIV the magic cure?”. South China Morning Post (4 February 2020). 2021年6月15日閲覧。 “Bangkok and Hangzhou hospitals put combination remedies to the test.”
↑  “China's health officials say priority is to stop mild coronavirus cases from getting worse.”. South China Morning Post (4 February 2020). 2021年6月15日閲覧。
↑  “Drug treatment options for the 2019-new coronavirus (2019-nCoV)”. Bioscience Trends 14 (1):  69–71. (January 2020). doi:10.5582/bst.2020.01020. PMID 31996494.
↑  Jun, Chen; Yun, Ling; Xiuhong, Xi; Ping, Liu; Feng, Li; Tao, Li; Zhiyin, Shang; Mei, Wang et al. (2020-02-21). “Efficacies of lopinavir/ritonavir and arbidol in the treatment of novel coronavirus pneumonia” (中国語). Chinese Journal of Infectious Diseases 38:  E008. doi:10.3760/cma.j.cn311365-20200210-00050. ISSN 1000-6680. http://rs.yiigle.com/yufabiao/1182592.htm.
↑  “АРБИДОЛ (ARBIDOL)”. Vidal. 4 February 2009時点のオリジナルよりアーカイブ。2021年6月15日閲覧。
↑  “Resolution”. Meetings of the Presidium of the Formulary Committee.   Russian Academy of Medical Sciences (16 March 2007). 2021年6月15日閲覧。
↑  “How do we plant federal ministers” (ロシア語). MKRU (21 April 2011). 2021年6月15日閲覧。
↑  Golunov, Ivan (23 December 2013). “13 most popular flu cures: do they work?” (ロシア語). Professional Journalism Platform. 2021年6月15日閲覧。
↑  Reuters, Svetlana. “Stick in the wheel” (ロシア語). Esquire. 2021年6月15日閲覧。
↑  “Repetition - the mother of learning” (ロシア語). Esquire. 2021年6月15日閲覧。